Abstract:In the last two decades, morbidity and mortality of patients with chronic heart failure could be further reduced by improved pharmacological and cardiac device therapies. However, despite these advances, there is a substantial unmet need for novel therapies, ideally specifically addressing repair and regeneration of the damaged or lost myocardium and its vasculature, given the limited endogenous potential for renewal of cardiomyocytes in adults. In this respect, cardiac cell-based therapies have gained substantial attention and have entered clinical feasibility and safety studies a decade ago. Different cell-types have been used, including bone marrow-derived mononuclear cells, bone marrow-derived mesenchymal stem cells, mobilized CD34+ cells, and more recently cardiac-derived c-kit+ stem cells and cardiosphere-derived cells. Some of these studies have suggested a potential of cell-based therapies to reduce cardiac scar size and to improve cardiac function in patients with ischemic cardiomyopathy. While first clinical trials examining the impact of cardiac cell-based therapy on clinical outcome have now been initiated, improved understanding of underlying mechanisms of action of cell-based therapies may lead to strategies for optimization of the cardiac repair potential of the applied cells. In experimental studies, direct in vivo reprogramming of cardiac fibroblasts towards cardiomyocytes, and microRNA-based promotion of cardiomyocyte proliferation and cardiac repair have recently been reported that may represent novel therapeutic approaches for cardiac regeneration that would not need cell-administration but rather directly stimulate endogenous cardiac regeneration. This review will focus mainly on recently completed clinical trials (within the last 2 years) investigating cardiac cell-based therapies and the current status of experimental studies for cardiac cell-based repair and regeneration with a potential for later translation into clinical studies in the future.

Gene and Cell‐based Therapies for Heart Disease

Gene- and Cell-Based Therapies for Cardiovascular Diseases: Current Status and Future Directions

Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular Disease

Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation

Gene delivery approaches to heart failure treatment

The Recent Advances in Cell Delivery Approaches, Biochemical and Engineering Procedures of Cell Therapy Applied to Coronary Heart Disease

Cell Therapy and 3D Regenerative Tissue to Remodel Heart Failure

Advanced cell and gene therapies in cardiology

Gene Therapy for Cardiovascular Disease: Clinical Perspectives

Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications.

The Challenges Of Stem Cell Therapy In Myocardial Infarction And Heart Failure And The Potential Strategies To Improve The Outcomes

Cardiovascular gene therapy for myocardial infarction

Gene therapy for cardiac diseases: methods, challenges, and future directions

Non-Viral Gene Delivery Systems for Treatment of Myocardial Infarction: Targeting Strategies and Cardiac Cell Modulation

Gene Therapy for Cardiovascular Disease: Basic Research and Clinical Prospects

Trials and tribulations of cell therapy for heart failure: an update on ongoing trials

Gene and stem cell therapy for inherited cardiac arrhythmias

Regenerative Therapy for Cardiomyopathies

Current status of cell-based therapy for heart failure

The Origin, Progress, and Application of Cell‐based Cardiac Regeneration Therapy

Myocardial regeneration: present and future trends